Literature DB >> 33516669

The JAID/JSC guidelines to Clinical Management of Infectious Disease 2017 concerning male urethritis and related disorders.

Ryoichi Hamasuna1, Mitsuru Yasuda2, Satoshi Takahashi3, Shinya Uehara4, Yasuhiro Kawai5, Isao Miyairi6, Soichi Arakawa7, Hiroshi Kiyota8.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33516669     DOI： 10.1016/j.jiac.2019.12.001

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN： 1341-321X            Impact factor:   2.211


× No keyword cloud information.
  3 in total

1.  Randomized controlled trial of the relative efficacy of high-dose intravenous ceftriaxone and oral cefixime combined with doxycycline for the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae co-infection.

Authors:  Phuong Thi Thu Nguyen; Ha Viet Pham; Dung Hoang Van; Linh Van Pham; Hoi Thanh Nguyen; Hung Van Nguyen
Journal:  BMC Infect Dis       Date:  2022-07-09       Impact factor: 3.667

2.  National surveillance of Neisseria gonorrhoeae antimicrobial susceptibility and epidemiological data of gonorrhoea patients across Brazil, 2018-20.

Authors:  Hanalydia de Melo Machado; Jéssica Motta Martins; Marcos André Schörner; Pamela Cristina Gaspar; Alisson Bigolin; Mauro Cunha Ramos; Willian Antunes Ferreira; Gerson Fernando Mendes Pereira; Angélica Espinosa Miranda; Magnus Unemo; Maria Luiza Bazzo
Journal:  JAC Antimicrob Resist       Date:  2022-07-05

3.  A Single Amino Acid Substitution in Elongation Factor G Can Confer Low-Level Gentamicin Resistance in Neisseria gonorrhoeae.

Authors:  Concerta L Holley; Vijaya Dhulipala; Jacqueline T Balthazar; Adriana Le Van; Afrin A Begum; Shao-Chun Chen; Timothy D Read; Mitch Matoga; Irving F Hoffman; Daniel Golparian; Magnus Unemo; Ann E Jerse; William M Shafer
Journal:  Antimicrob Agents Chemother       Date:  2022-04-25       Impact factor: 5.938
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.